ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Advicenne

Advicenne (ALDVI)

2.00
-0.02
(-0.99%)
Closed February 04 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.00
Bid
2.00
Ask
2.01
Volume
29,947
2.00 Day's Range 2.06
0.827 52 Week Range 3.06
Market Cap
Previous Close
2.02
Open
2.02
Last Trade
1986
@
2
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
25,792
Shares Outstanding
9,933,732
Dividend Yield
-
PE Ratio
-2.83
Earnings Per Share (EPS)
-0.71
Revenue
3.48M
Net Profit
-7.03M

About Advicenne

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Advicenne is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALDVI. The last closing price for Advicenne was 2.02 €. Over the last year, Advicenne shares have traded in a share price range of 0.827 € to 3.06 €.

Advicenne currently has 9,933,732 shares outstanding. The market capitalization of Advicenne is 20.07 € million. Advicenne has a price to earnings ratio (PE ratio) of -2.83.

ALDVI Latest News

Advicenne Announces its 2025 Financial Calendar

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those...

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

 After distal Renal Tubular Acidosis (dRTA) in December 2022, ADV7103 is granted "orphan drug" status in the United States in cystinuria. A long-awaited milestone for the Company and its...

Advicenne annonce les résultats de son augmentation de capital avec maintien du droit préférentiel de souscription

Souscription à hauteur de 5,7 M€ représentant 95% du montant initial Cemag Invest et Bpifrance détiennent respectivement 18,0% et 21,6% du capital et 17,6% et 23,6% des droits de vote  ...

Advicenne : Lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription afin d’accélérer la croissance en Europe et d’optimiser le développement clinique de ADV7103

Augmentation de capital avec maintien du droit préférentiel de souscription (le “DPS”) d’un montant initial de 6,0 M€, pouvant être porté à 6,9 M€ en cas d’exercice intégral de la clause...

Advicenne annonce le lancement de Sibnayal® au Danemark

Sibnayal® (citrate de potassium / bicarbonate de potassium) commercialisé depuis le 1er Mars 2023 Le prix de référence correspond à un coût de traitement annuel de 15.000 euros par patient...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0120.6036217303821.9882.11.948263902.01380707DE
40.0341.729399796541.9662.21.84272282.00712142DE
12-0.125-5.882352941182.1252.21.55257921.95972022DE
260.95491.20458891011.0462.390.85379801.7758889DE
520.2413.63636363641.763.060.827461911.80482392DE
156-4.5-69.23076923086.56.80.827283782.72204794DE
260-4.5-69.23076923086.56.80.827283782.72204794DE

ALDVI - Frequently Asked Questions (FAQ)

What is the current Advicenne share price?
The current share price of Advicenne is 2.00 €
How many Advicenne shares are in issue?
Advicenne has 9,933,732 shares in issue
What is the market cap of Advicenne?
The market capitalisation of Advicenne is EUR 20.07M
What is the 1 year trading range for Advicenne share price?
Advicenne has traded in the range of 0.827 € to 3.06 € during the past year
What is the PE ratio of Advicenne?
The price to earnings ratio of Advicenne is -2.83
What is the cash to sales ratio of Advicenne?
The cash to sales ratio of Advicenne is 5.7
What is the reporting currency for Advicenne?
Advicenne reports financial results in EUR
What is the latest annual turnover for Advicenne?
The latest annual turnover of Advicenne is EUR 3.48M
What is the latest annual profit for Advicenne?
The latest annual profit of Advicenne is EUR -7.03M
What is the registered address of Advicenne?
The registered address for Advicenne is 262, RUE DU FAUBOURG, PARIS, PARIS, 75008
What is the Advicenne website address?
The website address for Advicenne is www.advicenne.com
Which industry sector does Advicenne operate in?
Advicenne operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMIIM2I
8.15 €
(116.76%)
179.32k
ALMASMastrad
0.023 €
(69.12%)
23.61M
MLCOTCoretech 5
0.03 €
(42.86%)
9k
MLOCTOctopus Biosafety
0.193 €
(37.86%)
14.29k
ALPRGPrologue
0.269 €
(28.10%)
2.42M
BIODSBiosynex DS
0.0207 €
(-48.38%)
159.17k
GIM32Gimv NV
0.422 €
(-27.24%)
664.49k
ALNRGEnergisme SA
0.0032 €
(-17.95%)
33.42M
ALMDTMedian Technologies
3.35 €
(-17.69%)
456.99k
FIPPFipp
0.118 €
(-15.71%)
17.32k
ATOAtos SE
0.0021 €
(0.00%)
634.56M
ALVERVergnet
0.0009 €
(-10.00%)
53.04M
ALNRGEnergisme SA
0.0032 €
(-17.95%)
33.42M
ALCYBCybergun
0.0001 €
(0.00%)
27.08M
ALMASMastrad
0.023 €
(69.12%)
23.61M

Discussion

View Full Feed
pqr pqr 4 minutes ago
Thanks to muee and ATL.  On the money!
NWBO
trunkmonk trunkmonk 6 minutes ago
Pulte may get in, if he does and he is part of release, ill return the favor and buy a new Polte home in DFW area. ha
FNMA
doiling doiling 9 minutes ago
Something up.  Be aware.
RONN
janice shell janice shell 11 minutes ago
LOLOL!!
Vexari Vexari 11 minutes ago
Goes back to the beginning

investorshub.advfn.com/boards/read_msg.aspx?message_id=168062986 Wednesday, March 02, 2022 1:47:47 PM
PFE
Jack-Squatt Jack-Squatt 11 minutes ago
Down another 22.5% today! There is no bottom to this stock. Even after the R/S takes effect the stock will continue to tank. It wont be long before they will have to do anther R/S. FDA approval is a pipe dream!
TNXP
StocksGoneWild StocksGoneWild 11 minutes ago
Same call...
SRM speaking @ MM 16:52

Yeah, thanks Duane. Yeah, so as I mentioned, we will touch softly on some of these things. One of the major projects we are engaged in at this point is one of our partners and it’s a company that I’m also involved in, and I’m a cofounder of
SRM
ProfitChaser ProfitChaser 11 minutes ago
I agree. Many here including myself already have a small position and are waiting to buy more when we see confirmation the company plans on communicating more. Right now is a good time to at least buy a starter if you want to get in cheap and add more when we get the confirmation. So many traders
GCAN
carlson carlson 11 minutes ago
Yeah I know it's Gold. I was just wondering if more gold goes in the hole than is on the surface area.
NBRI
PickStocks PickStocks 13 minutes ago
The 4th came and went.....no money
COOP
BadCuda BadCuda 14 minutes ago
So if you breakdown of the gold buy 2023
2204lbs=90.5 mil at current price , they bought it for 66 million 2023. 
Adding 27.5 million in profit to company  upon delivery , 
27.5 million increase in value of 255 million share company is about .1058 cents per share . 
But 9
BHAT
FACT-MASTER FACT-MASTER 16 minutes ago
Amgen released 4th quarter details today with a significant increase in sales of Repatha:


https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-profit-beats-estimates-next-maritide-studies-start-by-mid-year-2025-02-04/

"The company's fourth-quarter s
ESPR
Sideem Sideem 16 minutes ago
Congrats Nelson!!! A good problem to have. 🤑
BB
rooster rooster 20 minutes ago
We’re just getting back all that money the Feds take from our oil
Bigfootbud Bigfootbud 20 minutes ago
$RDGL!!! :) :) :)
RDGL
shajandr shajandr 20 minutes ago
I bin skipping reading the last few daze of posts on diss bored, and I did a half-day lift ticket today - first time skiing since two years ago as I was in Kornland all last winter. Ergo I am sore and will be really sore manana - especially that first roll~OUTT of bed in the mourning/afternoon.
drugmanrx drugmanrx 22 minutes ago
You should try reading things before you post them and make erroneous comments " .No, it's not a "credibility endorsement" or a "partnership".

Seem like Careington takes it partners credibility were seriously

MARKETING PARTNER GUIDELINES

https://agent.car
CNNA
k9narc k9narc 22 minutes ago
I'm still speechless, and that's probably a good thing.

https://investorshub.advfn.com/uimage/uploads/2025/2/4/iiabpistockphoto-854560332-612x612.jpg
BigBadWolf BigBadWolf 22 minutes ago
Decide which best explains that which is clearly visible on $RDAR's everywhere for yourselves

Personal Bias or Frustration:
They may have had a negative experience with the stock, such as losing money, and their posts reflect their frustration or bias.

Desire
RDAR
JohnnyRodz JohnnyRodz 25 minutes ago
I Corntend that there will be plenty of Gold and Silver processed soon at AABB's facility in Ezatlan Mexico! It will be AMAIZINGGGGGGGGGGGGGGG! Corn Puns Intended!
AABB
236T568 236T568 27 minutes ago
Oopsie
https://x.com/ChrisDJackson/status/1886919806957301780?s=19
Vexari Vexari 28 minutes ago
Understanding what cancer is

Will lead to its prevention

Breaking the matrix
MRNA
arizona1 arizona1 28 minutes ago
I need more popcorn

You need to lay off the fentanyl.
Hardazoak Hardazoak 29 minutes ago
Right all NFTs sold out. All aabbg will be sold too. Can't wait.
AABB

Your Recent History

Delayed Upgrade Clock